XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

Pharmaceutical Technology

AUGUST 11, 2023

In June, Sutro received a $140m payment from Blackstone Life Sciences as part of the Vaxcyte product licensing agreement.

Life Science 130

Life Science Licensing Licensing Production 130

XTalks

NOVEMBER 8, 2023

In this episode, Ayesha talked about the FDA’s acceptance of AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Vaccination Vaccine Licensing 52

BioTech 365

SEPTEMBER 1, 2021

Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement … Continue reading →

Life Science 52

Life Science Licensing Licensing Antibody 52

pharmaphorum

JUNE 3, 2021

The arrival of G7 health ministers to Oxford this week (Thursday 3 June) will shine a spotlight on Oxfordshire’s considerable achievements in the life sciences sector – and, according to the county’s Local Enterprise Partnership, there couldn’t be a better location globally for this summit to be held.

Life Science 52

Life Science Vaccination Vaccine Development 52

pharmaphorum

OCTOBER 28, 2022

Although some life sciences companies are starting to shift to incorporate human-centered design practices, it is often coming late in the drug development process – well into the commercialisation efforts of launch planning, if not post-launch. gain insights to inform trial design and optimal target product profiles.

Life Science 99

Life Science Production Development Drugs 99

Pharmaceutical Technology

MARCH 2, 2023

The growth in sales was driven by all regions and business sectors, particularly Life Science. to €10.38bn in its Life Science business during the year. The EBITDA pre of Life Science grew by 14.4% Merck has reported an increase in group net sales by 12.9% to €22.23bn in fiscal 2022 against €19.68bn in 2021.

Sales 245

Sales Life Science Licensing Licensing 245

XTalks

AUGUST 10, 2022

In this episode, Ayesha discussed a new COVID-19 test technology that Innova Medical Group, world leader in at-home COVID-19 tests, has reached a licensing deal for with the University of Birmingham where the technology was developed. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science FDA Approval Drugs Licensing 52

pharmaphorum

MAY 12, 2021

The UK government used the Queen’s Speech to set out its ambition to make the country a leader in life sciences, garnering a warm response from industry groups. . Further support for vaccine rollout UK to lead the world in life sciences ‍ A new Life Time Skills Guarantee New NHS legislation to boost care quality.

Life Science 54

Life Science Vaccination Vaccine Research 54

FDA Law Blog

MAY 4, 2022

is pleased to announce that Sophia Gaulkin will be speaking on an expert panel at the 20th Advanced Summit on Life Sciences Patents , which is being held virtually and in-person in New York City on June 2-3, 2022. Hyman, Phelps & McNamara, P.C.

Life Science 40

Life Science Drugs Licensing Licensing 40

Drug Channels

OCTOBER 19, 2020

16th Annual Life Sciences Trade and Channel Strategies. December 1-3, 2020 | Virtual Event www.informaconnect.com/trade-channel. Get ready to hit the ground running in 2021 by closing out the year at Trade and Channel 2020 !

Life Science 52

Life Science Pharmacy Gene Therapy Gene 52

Pharmaceutical Commerce

MARCH 29, 2024

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the hottest therapeutic settings for dealmaking activity at the moment—and one platform approach in particular poised to be at the center of future M&A and licensing pursuits.

Life Science 52

Life Science Licensing Licensing 52

BioTech 365

AUGUST 17, 2020

SEOUL, South Korea & NANJING, China–(BUSINESS WIRE)–#NASH–LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co.

Life Science 52

Life Science Licensing Licensing 52

Drug Discovery World

JANUARY 17, 2024

ERS Genomics, a CRISPR/Cas9 licensing company, and StemSight, a biotechnology company developing stem cell based therapies for corneal blindness, have entered a non-exclusive CRISPR/Cas9 license agreement. The company provides licensing for companies interested in pursuing CRISPR/Cas9’s use in their commercial programmes.

Licensing 52

Licensing Licensing Genome Genomics 52

BioSpace

SEPTEMBER 8, 2021

Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

RNA 90

RNA Licensing Licensing Life Science 90

BioTech 365

SEPTEMBER 15, 2020

DOUGLAS, Isle of Man–(BUSINESS WIRE)–Juvenescence Limited (“Juvenescence”), a life sciences company focused on modifying aging and increasing human healthspan, announced today a partnership with Evgen Pharma plc to license its sulforaphane stabilization technology for use in several non-pharmaceutical applications led … (..)

Licensing 40

Licensing Licensing Life Science 40

Drug Discovery World

MAY 12, 2023

Inspired by the relaunch of PerkinElmer’s Life Science and Diagnostics business this week as Revvity, my top five news story this week all relate to new drug discovery business developments. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Drugs Licensing Licensing 52

pharmaphorum

MARCH 16, 2021

Nuclear Regulatory Commission (NRC) has issued a Materials License for its new Indianapolis, IN headquarters. The license also expands SpectronRx’s roster of authorized nuclear pharmacists and authorized users. The license lists more than 25 different isotopes, ranging from Lutetium-177, Actinium-225, Iodine-131,and Iodine-123.

Licensing 52

Licensing Licensing Manufacturing Pharmacy 52

BioSpace

MARCH 14, 2021

Nearly five years to the day after striking the deal, AVEO Oncology and CANbridge Life Sciences announce the termination of their collaboration and licensing agreement for AVEO’s AV-203.

Life Science 97

Life Science Antibody Licensing Licensing 97

Drug Discovery Today

JANUARY 26, 2022

a leading provider of integrated drug discovery services to life science organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing agreement with Ipsen. Saffron Walden, 26th January 2022 / Domainex Ltd.,

Licensing 40

Licensing Licensing Life Science Manufacturing 40

The Pharma Data

SEPTEMBER 29, 2020

Mechanisms for rapidly escalating supply must be aligned with the specific context of a rapid pandemic response and tailored to each product, with options including early voluntary licensing and appropriate approaches to peer-to-peer innovator company manufacturing agreements. . Enable affordability for lower income countries.

Life Science 52

Life Science Production Vaccination Vaccine 52

BioSpace

JANUARY 13, 2021

Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

Licensing 56

Licensing Licensing Life Science 56

The Pharma Data

JUNE 14, 2023

About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Cedilla will also be eligible to receive royalties on medicines based on their technology commercialized by Bayer. Financial details have not been disclosed.

Licensing 40

Licensing Licensing Life Science Development 40

Drug Discovery World

JANUARY 25, 2024

The UK’s life sciences and biotech sector showed resilience in 2023, securing £1.8 ($2.2) Major licensing and M&A deals demonstrate the ongoing quality and attractiveness of UK science. The UK takes the lead in Europe with the highest number of clinical-stage companies.

Life Science 52

Life Science Licensing Licensing Gene Therapy 52

STAT News

NOVEMBER 29, 2022

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.    Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

Life Science 98

Life Science Licensing Licensing Marketing 98

Delveinsight

DECEMBER 8, 2020

KaliVir, Astellas Pharma forms a licensing deal for VET2-L2 oncolytic virus. KaliVir Immunotherapeutics and Astellas Pharma entered into a worldwide exclusive licensing agreement for the development, research, and commercialization of VET2-L2 to widen the horizon of therapeutic approaches available in the Immuno-Oncology market.

Licensing 52

Licensing Licensing Gene Therapy Antibody 52

XTalks

JANUARY 3, 2024

Novartis and Voyager Therapeutics have struck a licensing deal that will see Novartis pay Voyager $100 million upfront to develop gene therapy candidates targeting Huntington’s disease (HD) and spinal muscular atrophy (SMA). The total value of the deal could potentially reach $1.2

Gene Therapy 52

Gene Therapy Gene Licensing Licensing 52

The Pharma Data

DECEMBER 20, 2020

Allecra, subject to the satisfaction of terms and conditions as set forth in the Exclusive Licensing Agreement, is to receive an upfront cash payment and is eligible to receive additional development and commercial milestone payments with an overall deal value of $78 million, in addition to royalties.

Licensing 40

Licensing Licensing Life Science Manufacturing 40

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany.

Drugs 59

Drugs Life Science Gene Editing Gene 59

XTalks

JANUARY 26, 2022

A field application scientist is a valuable member of any life science company due to their direct interaction with customers. An application scientist typically works for life science companies that manufacture laboratory tools or provide a service for laboratory use. Field Scientist Job Description.

Scientist 98

Scientist Life Science Production Sales 98

pharmaphorum

OCTOBER 12, 2022

Remaining compliant is imperative to the life sciences industry, so adhering to regulatory requirements is mandatory. The provision of these records must be readily available for auditing, and failing such regulatory audits can ultimately result in a license withdrawal. As the industry increases the adoption of Pharma 4.0,

Compliance 98

Compliance Manufacturing Life Science Production 98

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. It aims to shape companies in the digital healthcare, connected medical devices, and life sciences spaces.

Life Science 105

Life Science Development Business Development Genetics 105

Pharmaceutical Technology

DECEMBER 14, 2022

Under the deal, Merck will license its VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications.

Gene Therapy 130

Gene Therapy Gene Development Manufacturing 130

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. As a result, multiple vaccines, including Pfizer /BioNTech’s mRNA vaccine, Comirnaty, were licensed for use within a year of development beginning.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

The Pharma Data

DECEMBER 20, 2020

” Under the License Agreement, Peijia and HighLife will establish a joint review committee to enhance a mutual sharing of information about the development as well as commercialization of the TMVR products, further deepening cooperation between the two companies. SUZHOU, China and PARIS , Dec.

Licensing 40

Licensing Licensing Production Marketing 40

pharmaphorum

MARCH 9, 2021

Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors.

Life Science 52

Life Science Licensing Licensing Scientist 52

pharmaphorum

JANUARY 30, 2022

2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top life science hubs and apparently shrugging off the effects of the pandemic and Brexit. “History has handed the UK two world-leading sectors: life sciences and finance.

Life Science 97

Life Science Allergies DNA Licensing 97